Literature DB >> 26881779

Endovascular Treatment of Acute Ischemic Stroke Due to Tandem Occlusions: Large Multicenter Series and Systematic Review.

Mikayel Grigoryan1, Diogo C Haussen, Ameer E Hassan, Andrey Lima, Jonathan Grossberg, Leticia C Rebello, Wondwossen Tekle, Michael Frankel, Raul G Nogueira.   

Abstract

BACKGROUND: Ischemic strokes due to tandem occlusions (TOs) have poor outcomes if they have been treated with only medical interventions. Recent trials demonstrated the effectiveness of endovascular treatment of acute ischemic stroke due to intracranial occlusions; however, most studies excluded patients with TOs.
METHODS: Retrospective review of prospectively collected thrombectomy databases from 3 stroke centers between 2011 and 2015. Consecutive patients with tandem extracranial steno-occlusive carotid disease and intracranial occlusions who underwent emergent thrombectomy were selected. Angiographic and clinical outcomes were analyzed; baseline and procedural variables were included in univariate and multivariate analyses to define the independent predictors of good outcomes (90-day modified Rankin Scale ≤2).
RESULTS: A total of 100 patients met the study inclusion criteria. The mean age was 64.4 ± 12.5, baseline National Institutes of Health Stroke Scale (NIHSS) 17.6 ± 5.0, time from last known well to puncture 7.3 ± 5.8 h, and Alberta Stroke Program Early CT Score (ASPECTS) 7.5 ± 1.6. Forty percent received intravenous tissue plasminogen activator. Intracranial occlusion sites included: internal carotid artery thrombus, 31%; middle cerebral artery (MCA)-M1, 53%; MCA-M2, 10%; and anterior cerebral artery, 6%. Good outcome was achieved in 42% and successful reperfusion modified thrombolysis in cerebral infarction (mTICI ≥2B) in 88% of the cases, including complete (mTICI 3) reperfusion in 40%. Severe parenchymal hematoma (PH)-2 occurred in 6% of the patients and 90-day mortality was 20%. In the multivariate analysis, younger age (OR 0.93; 95% CI 0.88-0.98; p = 0.004), lower baseline NIHSS (OR 0.84; 95% CI 0.74-0.94; p = 0.003), higher ASPECTS (OR 1.50; 95% CI 1.02-2.19; p = 0.038), and mTICI 3 reperfusion (OR 3.56; 95% CI 1.18-10.76; p = 0.024) were independent predictors of good outcome at 90 days.
CONCLUSIONS: Acute endovascular treatment of tandem anterior circulation occlusions yields good outcomes and has similar outcome predictors to isolated intracranial occlusions. Given their comparable clinical behavior, these patients should be included in future trials.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 26881779     DOI: 10.1159/000444069

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  25 in total

1.  Carotid angioplasty-assisted mechanical thrombectomy without urgent stenting may be a better option in acute tandem occlusions.

Authors:  Cetin K Akpinar; Erdem Gürkaş; Emrah Aytac
Journal:  Interv Neuroradiol       Date:  2017-05-15       Impact factor: 1.610

2.  Retriever wire supported carotid artery revascularization (ReWiSed CARe) in acute ischemic stroke with underlying tandem occlusion caused by an internal carotid artery dissection: Technical note.

Authors:  Daniel Behme; Michael Knauth; Marios-Nikos Psychogios
Journal:  Interv Neuroradiol       Date:  2017-02-05       Impact factor: 1.610

3.  Endovascular treatment of acute internal carotid artery dissections: technical considerations, clinical and angiographic outcome.

Authors:  Wiebke Kurre; Kai Bansemir; Marta Aguilar Pérez; Rosa Martinez Moreno; Elisabeth Schmid; Hansjörg Bäzner; Hans Henkes
Journal:  Neuroradiology       Date:  2016-10-29       Impact factor: 2.804

4.  Simultaneous revascularization of the occluded internal carotid artery using the Solitaire as a workhorse wire during acute ischemic stroke intervention.

Authors:  Alexandra R Paul; Pouya Entezami; Emad Nourollahzadeh; John Dalfino; Alan S Boulos
Journal:  Interv Neuroradiol       Date:  2019-11-07       Impact factor: 1.610

5.  Use of Cangrelor in Cervical and Intracranial Stenting for the Treatment of Acute Ischemic Stroke: A "Real Life" Single-Center Experience.

Authors:  A Cervo; F Ferrari; G Barchetti; L Quilici; M Piano; E Boccardi; G Pero
Journal:  AJNR Am J Neuroradiol       Date:  2020-10-08       Impact factor: 3.825

6.  Emergent carotid artery stenting in patients with acute ischemic stroke due to cervical internal carotid artery steno-occlusive lesion: Comparison of tandem intracranial occlusion and isolated cervical internal carotid artery occlusion.

Authors:  Sung E Park; Dae S Choi; Hye J Baek; Kyeong H Ryu; Ji Y Ha; Ho C Choi; Sangmin Lee; Jungho Won; Seunguk Jung
Journal:  Interv Neuroradiol       Date:  2020-01-28       Impact factor: 1.610

7.  The use of cangrelor in neurovascular interventions: a multicenter experience.

Authors:  Gustavo M Cortez; André Monteiro; Nader Sourour; Frédéric Clarençon; Mahmoud Elhorany; Mikayel Grigoryan; Soz Mirza; Guilherme Dabus; Italo Linfante; Pedro Aguilar-Salinas; Yasmeen Murtaza; Amin Aghaebrahim; Eric Sauvageau; Ricardo A Hanel
Journal:  Neuroradiology       Date:  2020-11-11       Impact factor: 2.804

8.  Combined surgical and interventional treatment of tandem carotid artery and middle cerebral artery embolus: A case report.

Authors:  Meng Zhang; Ji-Heng Hao; Kai Lin; Qing-Ke Cui; Li-Yong Zhang
Journal:  World J Clin Cases       Date:  2020-02-06       Impact factor: 1.337

9.  Anterior Circulation Acute Ischemic Stroke Associated with Atherosclerotic Lesions of the Cervical ICA: A Nosologic Entity Apart.

Authors:  O F Eker; P Panni; C Dargazanli; G Marnat; C Arquizan; P Machi; I Mourand; G Gascou; E Le Bars; V Costalat; A Bonafé
Journal:  AJNR Am J Neuroradiol       Date:  2017-10-19       Impact factor: 3.825

10.  Endovascular retrograde approach may be a better option for acute tandem occlusions stroke.

Authors:  Dong Yang; Zhonghua Shi; Min Lin; Zhiming Zhou; Wenjie Zi; Huaiming Wang; Yonggang Hao; Fuqiang Guo; Wenhua Liu; Gelin Xu; Yunyun Xiong; Xinfeng Liu
Journal:  Interv Neuroradiol       Date:  2018-10-05       Impact factor: 1.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.